Acute promyelocytic leukemia, hypogranular variant: a rare presentation

被引：6

作者：

Akhtar, Kafil ^{[1
]}

Ahmad, Shamshad ^{[1
]}

Sherwani, Rena K. ^{[1
]}

机构：

[1] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Pathol, Aligarh, UP, India

来源：

CLINICS AND PRACTICE | 2011年 / 1卷 / 01期

关键词：

acute promyelocytic leukemia; hypogranular variant; cytochemistry;

D O I：

10.4081/cp.2011.e11

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Early diagnosis of acute promyelocytic leukemia (APL) is essential because of its associated life threatening coagulopathy and unique response to all trans-retinoic acid (ATRA) therapy. The characteristic cell morphology supplemented by cytochemistry offers the most rapid means for diagnosis. Here we describe a rare case of acute promyelocytic leukemia-hypogranular variant that poses particular diagnostic challenge.

引用

页码：18 / 19

页数：2

共 8 条

[1] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&

[2]

GRIGNANI F, 1994, BLOOD, V83, P10

[3] CD2+ tetraploid acute promyelocytic leukemia variant with double (15;17) translocations [J].

Kaito, K ;

Otsubo, H ;

Dobashi, N ;

Usui, N ;

Kobayashi, M .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (01) :29-31

[4]

Redaelli Alberto, 2003, Expert Rev Anticancer Ther, V3, P695

[5] Acute promyelocytic leukemia M3: Cytomorphologic, immunophenotypic, cytogenetic, and molecular variants [J].

Sucic, M ;

Zadro, R ;

Burazer, B ;

Labar, B ;

Nemet, D ;

Mrsic, M ;

Aurer, I ;

Mrsic, S ;

Hitrec, V ;

Boban, D ;

Markovic-Glamocak, M ;

Batinic, D ;

Uzarevic, B ;

Stavljenic-Rukavina, A .

JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (06) :941-950

[6] Long-term follow-up and potential for cure in acute promyelocytic leukaemia [J].

Tallman, MS ;

Rowe, JM .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (03) :535-543

[7] All-trans retinoic acid in acute promyelocytic leukemia:: long-term outcome and prognostic factor analysis from the North American Intergroup protocol [J].

Tallman, MS ;

Andersen, JW ;

Schiffer, CA ;

Appelbaum, FR ;

Feusner, JH ;

Woods, WG ;

Ogden, A ;

Weinstein, H ;

Shepherd, L ;

Willman, C ;

Bloomfield, CD ;

Rowe, JM ;

Wiernik, PH .

BLOOD, 2002, 100 (13) :4298-4302

[8] Acute promyelocytic leukemia: evolving therapeutic strategies [J].

Tallman, MS ;

Nabhan, C ;

Feusner, JH ;

Rowe, JM .

BLOOD, 2002, 99 (03) :759-767

← 1 →